Regentis Biomaterials Ltd. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RGNT NYSE American 2836 www.regentis.co.il

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Regentis Biomaterials Ltd.

Regentis' GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation - Jan 6th, 2026 6:21 am
Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC - Dec 18th, 2025 6:35 am
Regentis Biomaterials Commences Trading on NYSE: Set to Transform Cartilage Repair Market with Off-the-Shelf Regenerative Product - Dec 8th, 2025 6:33 am
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering - Dec 5th, 2025 2:10 pm
Sector Update: Health Care Stocks Slide Late Afternoon - Dec 4th, 2025 2:01 pm
Sector Update: Health Care Stocks Softer in Afternoon Trading - Dec 4th, 2025 11:52 am
Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering - Dec 3rd, 2025 5:23 pm